DBV Technologies (DBVT) Total Current Liabilities (2015 - 2026)

DBV Technologies (DBVT) reported Total Current Liabilities of $51.8 million for Q1 2026, up 28.27% year-over-year from $40.4 million in Q1 2025, and down 10.69% quarter-over-quarter from $58.0 million in Q4 2025.

DBV Technologies (DBVT) Total Current Liabilities (2015 - 2026) Analysis & Trends

DBV Technologies (DBVT) has 12 years of Total Current Liabilities data on file, last reported at $51.8 million in Q1 2026.

  • Total Current Liabilities for Q1 2026 came in at $51.8 million, up 28.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $51.8 million (up 28.27% YoY), and the FY2025 annual result was $58.0 million, up 86.28% from the prior year.
  • Total Current Liabilities slipped to $51.8 million in Q1 2026 per DBVT's latest filing, from $58.0 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $58.0 million in Q4 2025 and troughed at $26.0 million in Q1 2022.
  • A 5-year average of $36.1 million and a median of $31.4 million in 2023 frame the typical range for Total Current Liabilities.
  • The sharpest annual moves came in 2022 and 2025: Total Current Liabilities tumbled 32.96% in 2022, then surged 86.28% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $29.5 million in 2022, then advanced by 26.48% to $37.3 million in 2023, then slipped by 16.61% to $31.1 million in 2024, then jumped by 86.28% to $58.0 million in 2025, then fell by 10.69% to $51.8 million in 2026.
  • Business Quant data shows DBVT's Total Current Liabilities at $51.8 million in Q1 2026, $58.0 million in Q4 2025, and $49.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1.70 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 16.35 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 636.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 13.42 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 3.88 Bn
9 Abivax 91.96 Bn 91.96 Bn - 72.86 Mn
10 DBV Technologies 6.63 Bn 6.41 Bn -3.90 Mn 51.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 51.80 Mn
Dec 31, 2025 58.00 Mn
Sep 30, 2025 49.49 Mn
Jun 30, 2025 49.43 Mn
Mar 31, 2025 40.38 Mn
Dec 31, 2024 31.14 Mn
Sep 30, 2024 30.91 Mn
Jun 30, 2024 27.38 Mn
Mar 31, 2024 26.48 Mn
Dec 31, 2023 37.34 Mn
Sep 30, 2023 31.44 Mn
Jun 30, 2023 33.37 Mn
Mar 31, 2023 32.78 Mn
Dec 31, 2022 29.52 Mn
Sep 30, 2022 28.39 Mn
Jun 30, 2022 30.43 Mn
Mar 31, 2022 26.03 Mn
Dec 31, 2021 31.40 Mn
Sep 30, 2021 33.81 Mn
Jun 30, 2021 38.70 Mn